NRXP 8-K 2026-08-07

NRX Pharmaceuticals, Inc. (NRXP) 8-K dated 2026-08-07 — accession 0001437749-26-026428. This URL is the filing, not the NRXP hub.

NRX Pharmaceuticals, Inc. (NRXP) is a biotechnology company listed on US.

NRX Pharmaceuticals, Inc. filed a 8-K on 2026-08-07. Accession 0001437749-26-026428.

Cached items: 7.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NRXP revenue for 2025-12-31 was $1.2M. Net income was -$28.6M. NRXP currently screens at market cap $169.9M.

Not investment advice. The NRXP SEC hub lists recent forms. The stock page is the research view.